These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 16222552

  • 1. Does growth hormone therapy induce IgA nephropathy?
    Kano K, Nishikura K, Arisaka O.
    Pediatr Nephrol; 2005 Dec; 20(12):1821-2. PubMed ID: 16222552
    [No Abstract] [Full Text] [Related]

  • 2. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
    Brodsky SV, Rovin BH, Hebert LA.
    Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
    [No Abstract] [Full Text] [Related]

  • 3. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
    Woo KT, Lee GS, Pall AA.
    Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
    [No Abstract] [Full Text] [Related]

  • 4. Clinical effect of dipyridamole in patients with IgA nephropathy.
    Yagame M, Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
    [Abstract] [Full Text] [Related]

  • 5. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 6. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

  • 7. [Berger's disease or primary IgA nephropathy in children].
    Renoult E, Cochat P, Jonon B, Kessler M.
    Pediatrie; 1989 Jan; 44(5):365-74. PubMed ID: 2812962
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 9. Combined therapy in children and adolescents with IgA nephropathy.
    Murakami K, Yoshioka K, Akano N, Takemura T, Okada M, Aya N, Hino S, Miyazato H, Yagi K, Maki S.
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
    [Abstract] [Full Text] [Related]

  • 10. IgA nephropathy: a long-term progressive study.
    Orłowski T, Górski A, Rancewicz Z, Morzycka-Michalik M, Smogorzewski M, Małdyk M, Lao M, Szczesny-Nowicka B.
    Miner Electrolyte Metab; 1990 Jan; 16(1):54-6. PubMed ID: 2325593
    [Abstract] [Full Text] [Related]

  • 11. [Pathogenesis of IgA nephropathy: role of outer membranes of Haemophilus parainfluenzae antigens].
    Suzuki S, Gejyo F, Arakawa M.
    Nihon Rinsho; 1997 Jun; 55(6):1580-7. PubMed ID: 9200951
    [Abstract] [Full Text] [Related]

  • 12. Underglycosylation of IgA in IgA nephropathy: more than a diagnostic marker?
    Roos A, van Kooten C.
    Kidney Int; 2007 Jun; 71(11):1089-91. PubMed ID: 17522695
    [Abstract] [Full Text] [Related]

  • 13. [IgA nephropathy and intrahepatic percutaneous portosystemic shunt].
    Blanco Sampascual S, de las Heras Niño B, Marcé Landeta L, Orive Cura V.
    Gastroenterol Hepatol; 1999 Dec; 22(10):535-6. PubMed ID: 10650672
    [No Abstract] [Full Text] [Related]

  • 14. [A ciclosporin A responsive case of Behçet's disease associated with IgA nephropathy].
    Suemitsu T, Saga T, Inui A, Ariizumi M, Shogi E, Sato H.
    Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):189-94. PubMed ID: 8315882
    [Abstract] [Full Text] [Related]

  • 15. Chronic tonsillitis and IgA nephropathy.
    Zhou WG, Wang TF, Xue Y, Li N, Wu JG, Yu YS.
    Chin Med J (Engl); 1993 Oct; 106(10):770-2. PubMed ID: 8033611
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of IgA nephropathy by integrated traditional and Western medicine].
    Ye RG.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Jan; 12(1):17-9, 4. PubMed ID: 1627942
    [Abstract] [Full Text] [Related]

  • 17. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 18. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
    Woo KT, Chiang GS, Lim CH.
    Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
    [No Abstract] [Full Text] [Related]

  • 19. IgA nephropathy in cystic fibrosis.
    Bhatt N, Bhatt N.
    Clin Nephrol; 2007 Jun; 67(6):403-4. PubMed ID: 17598378
    [No Abstract] [Full Text] [Related]

  • 20. Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy.
    McEnery PT, McAdams AJ, West CD.
    Perspect Nephrol Hypertens; 1973 Jun; 1 Pt 1():305-20. PubMed ID: 4620921
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.